Literature DB >> 31243357

Dysregulation of the PD-1/PD-L1 pathway contributes to the pathogenesis of celiac disease.

Candelaria Ponce de León1, Miguel Angel López-Casado2, Pedro Lorite1, Teresa Palomeque1, María Isabel Torres3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31243357      PMCID： PMC6804637          DOI： 10.1038/s41423-019-0256-7

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN： 1672-7681            Impact factor:   11.530


× No keyword cloud information.
  13 in total

1.  Alternative splice variants of the human PD-1 gene.

Authors:  Christian Nielsen; Line Ohm-Laursen; Torben Barington; Steffen Husby; Søren T Lillevang
Journal:  Cell Immunol       Date:  2005-09-19       Impact factor: 4.868

2.  Recent insights into the role of the PD-1/PD-L1 pathway in immunological tolerance and autoimmunity.

Authors:  Elena Gianchecchi; Domenico Vittorio Delfino; Alessandra Fierabracci
Journal:  Autoimmun Rev       Date:  2013-06-20       Impact factor: 9.754

Review 3.  Role of PD-1 in regulating T-cell immunity.

Authors:  Hyun-Tak Jin; Rafi Ahmed; Taku Okazaki
Journal:  Curr Top Microbiol Immunol       Date:  2011       Impact factor: 4.291

4.  Depletion of the programmed death-1 receptor completely reverses established clonal anergy in CD4(+) T lymphocytes via an interleukin-2-dependent mechanism.

Authors:  Kenneth D Bishop; John E Harris; John P Mordes; Dale L Greiner; Aldo A Rossini; Michael P Czech; Nancy E Phillips
Journal:  Cell Immunol       Date:  2009-02-23       Impact factor: 4.868

5.  The interferon gamma gene in celiac disease: augmented expression correlates with tissue damage but no evidence for genetic susceptibility.

Authors:  Martin C Wapenaar; Martine J van Belzen; Justin H Fransen; Aranzazu Fariña Sarasqueta; Roderick H J Houwen; Jos W R Meijer; Chris J J Mulder; Cisca Wijmenga
Journal:  J Autoimmun       Date:  2004-09       Impact factor: 7.094

6.  Regulatory T-cell function is impaired in celiac disease.

Authors:  Marilena Granzotto; Sara dal Bo; Sara Quaglia; Alberto Tommasini; Elisa Piscianz; Erica Valencic; Fortunato Ferrara; Stefano Martelossi; Alessandro Ventura; Tarcisio Not
Journal:  Dig Dis Sci       Date:  2008-10-31       Impact factor: 3.199

7.  Potential role of the IL-33/ST2 axis in celiac disease.

Authors:  M A López-Casado; P Lorite; T Palomeque; M I Torres
Journal:  Cell Mol Immunol       Date:  2015-09-07       Impact factor: 11.530

8.  Celiac Disease Autoimmunity.

Authors:  Miguel Ángel López Casado; Pedro Lorite; Candelaria Ponce de León; Teresa Palomeque; Maria Isabel Torres
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2018-08-25       Impact factor: 4.291

9.  The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase.

Authors:  H Arentz-Hansen; R Körner; O Molberg; H Quarsten; W Vader; Y M Kooy; K E Lundin; F Koning; P Roepstorff; L M Sollid; S N McAdam
Journal:  J Exp Med       Date:  2000-02-21       Impact factor: 14.307

10.  IFN-γ from lymphocytes induces PD-L1 expression and promotes progression of ovarian cancer.

Authors:  K Abiko; N Matsumura; J Hamanishi; N Horikawa; R Murakami; K Yamaguchi; Y Yoshioka; T Baba; I Konishi; M Mandai
Journal:  Br J Cancer       Date:  2015-03-31       Impact factor: 7.640
View more
  6 in total

1.  Characteristics, treatment, and outcome of diverticulitis after immune checkpoint inhibitor treatment in patients with malignancies.

Authors:  Austin R Thomas; Mostafa Eyada; Anusha S Thomas; Yinghong Wang; Miho Kono; Krishnavathana Varatharajalu; Yang Lu; Guofan Xu; Kavea Panneerselvam; Malek Shatila; Mehmet Altan; Jennifer Wang; John A Thompson; Hao Chi Zhang; Muhammad Ali Khan; Gottumukkala S Raju
Journal:  J Cancer Res Clin Oncol       Date:  2022-10-15       Impact factor: 4.322

Review 2.  Checkpoint Inhibitors and Induction of Celiac Disease-like Condition.

Authors:  Aaron Lerner; Carina Benzvi
Journal:  Biomedicines       Date:  2022-03-04

Review 3.  The Diverse Function of PD-1/PD-L Pathway Beyond Cancer.

Authors:  Weiting Qin; Lipeng Hu; Xueli Zhang; Shuheng Jiang; Jun Li; Zhigang Zhang; Xu Wang
Journal:  Front Immunol       Date:  2019-10-04       Impact factor: 7.561

Review 4.  Role of PD-L1 in Gut Mucosa Tolerance and Chronic Inflammation.

Authors:  Marina Chulkina; Ellen J Beswick; Irina V Pinchuk
Journal:  Int J Mol Sci       Date:  2020-12-01       Impact factor: 5.923

5.  Constitutive programmed death ligand 1 expression protects gastric G-cells from Helicobacter pylori-induced inflammation.

Authors:  Michiel C Mommersteeg; Bing Ting Yu; Thierry P P van den Bosch; Johan H von der Thüsen; Ernst J Kuipers; Michael Doukas; Manon C W Spaander; Maikel P Peppelenbosch; Gwenny M Fuhler
Journal:  Helicobacter       Date:  2022-07-28       Impact factor: 5.182

6.  Significance of PD1 Alternative Splicing in Celiac Disease as a Novel Source for Diagnostic and Therapeutic Target.

Authors:  Candelaria Ponce de León; Pedro Lorite; Miguel Ángel López-Casado; Francisco Barro; Teresa Palomeque; María Isabel Torres
Journal:  Front Immunol       Date:  2021-06-16       Impact factor: 7.561
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.